as on January 15, 2026 at 12:41 am IST
Day's Low
Day's High
2.35%
Downside
1.99%
Upside
52 Week's Low
52 Week's High
5.69%
Downside
238.41%
Upside
Check Janux Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$843.9M
EPS (TTM)
-1.9672
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-52.87
Industry PE ratio
7.7975
PEG Ratio
0EBITDA
-142.2M
Revenue (TTM)
10.0M
Profit Margin
0.00%
Return On Equity TTM
-12.48%
Track how Janux Therapeutics Inc P/E has moved over time to understand its valuation trends.
Janux Therapeutics Inc in the last 5 years
Lowest (-51.60x)
June 30, 2024
Today (-52.87x)
January 14, 2026
Industry (7.80x)
January 14, 2026
Highest (-5.24x)
September 30, 2021
Today’s Price to Earnings Ratio: -52.87x
Compare market cap, revenue, PE, and other key metrics of Janux Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $843.9M | NA | -52.87 | 0.00% | |
| BUY | $49.0B | 124.12% | 1236.37 | 1.36% | |
| BUY | $118.1B | 101.07% | 32.37 | 31.35% | |
| NA | $37.0B | NA | 630.17 | 1.38% | |
| BUY | $81.4B | 46.53% | 18.42 | 32.13% |
The Janux Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Janux Therapeutics Inc investment value today
Current value as on today
₹35,330
Returns
Returns from Janux Therapeutics Inc Stock
Dollar Returns*
₹4,327 (+4.33%)
Based on 15 analysts
93.33%
Buy
6.67%
Hold
0.00%
Sell
Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Janux Therapeutics Inc. Average target price of $64.29
Get share price movements and forecasts by analysts on Janux Therapeutics Inc.
What analysts predicted
78.13%UPSIDE
Target Price
$64.29
Current Price
$14.06
Analyzed by
15 Analysts
Target
$64.29
Janux Therapeutics Inc target price $64.29, a slight upside of 78.13% compared to current price of $14.06. According to 15 analysts rating.
Investment in Janux Therapeutics Inc Shares on INDmoney has dropped by -74.19% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Janux Therapeutics Inc Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 02 December
Tue, 10:03 PM
-Janux Therapeutics stock fell 47% after disappointing early-stage prostate cancer trial data.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -33.85M → -24.31M (in $), with an average increase of 39.3% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, -8.51M → 10.0M (in $), with an average increase of 185.1% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.7% return, outperforming this stock by 62.7%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 74.7% return, outperforming this stock by 144.3%
Price Dip
![]()
In the last 3 months, JANX stock has moved down by -46.4%
| Organisation | Janux Therapeutics Inc |
| Headquarters | 10955 Vista Sorrento Parkway, San Diego, CA, United States, 92130 |
| Industry | Services |
| CEO | Dr. David Alan Campbell Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. David Alan Campbell Ph.D. | President, CEO & Director |
Ms. Maria Dobek | Principal Accounting Officer & VP of Accounting |
Mr. James Pennington | General Counsel & Corporate Secretary |
Mr. Andy Hollman Meyer | Chief Business Officer |
Dr. Thomas Diraimondo Ph.D. | Chief Scientific Officer |
Mr. Matt Whitmire | Vice President of Finance |
Mr. Charles M. Winter | Chief Technical Officer |
Ms. Janeen Doyle | Chief Corporate & Business Development Officer |
Dr. Zachariah McIver D.O., Ph.D. | Chief Medical Officer |
Janux Therapeutics Inc share price today is $14.06 as on . Janux Therapeutics Inc share today touched a day high of $14.34 and a low of $13.73.
Janux Therapeutics Inc share touched a 52 week high of $47.58 on and a 52 week low of $13.26 on . Janux Therapeutics Inc stock price today i.e. is trending at $14.06,which is 70.45% down from its 52 week high and 6.03% up from its 52 week low.
Janux Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Janux Therapeutics Inc (JANX) shares with as little as ₹90.274 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.74 in Janux Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Janux Therapeutics Inc share’s latest price of $14.06 as on January 15, 2026 at 12:41 am IST, you will get 0.7112 shares of Janux Therapeutics Inc. Learn more about
fractional shares .